172 related articles for article (PubMed ID: 17222322)
1. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
2. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
3. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive monitoring of oxidant stress in alcoholic liver disease.
Pemberton PW; Smith A; Warnes TW
Scand J Gastroenterol; 2005 Sep; 40(9):1102-8. PubMed ID: 16165720
[TBL] [Abstract][Full Text] [Related]
5. Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease.
Latvala J; Hietala J; Koivisto H; Järvi K; Anttila P; Niemelä O
Am J Gastroenterol; 2005 Jun; 100(6):1303-10. PubMed ID: 15929761
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory cytokines in stable chronic alcoholics: relationship with fat and lean mass.
González-Reimers E; García-Valdecasas-Campelo E; Santolaria-Fernández F; de la Vega-Prieto MJ; Ros-Vilamajó R; Martínez-Riera A; Castellano-Higuera A; Rodríguez-Gaspar M
Food Chem Toxicol; 2007 Jun; 45(6):904-9. PubMed ID: 17210215
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue metabolism and alcohol intake in alcoholic liver disease.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Alcohol Alcohol Suppl; 1991; 1():351-5. PubMed ID: 1845562
[TBL] [Abstract][Full Text] [Related]
9. Patterns of IgA Autoantibody Generation, Inflammatory Responses and Extracellular Matrix Metabolism in Patients with Alcohol Use Disorder.
Niemelä O; Bloigu A; Bloigu R; Nivukoski U; Kultti J; Pohjasniemi H
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685930
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease.
Urbaschek R; McCuskey RS; Rudi V; Becker KP; Stickel F; Urbaschek B; Seitz HK
Alcohol Clin Exp Res; 2001 Feb; 25(2):261-8. PubMed ID: 11236841
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis.
Szuster-Ciesielska A; Daniluk J; Kandefer-Zerszeń M
Arch Immunol Ther Exp (Warsz); 2000; 48(4):301-7. PubMed ID: 11059648
[TBL] [Abstract][Full Text] [Related]
13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
[TBL] [Abstract][Full Text] [Related]
15. [Markers of hepatic fibrogenesis in alcoholic patients].
de la Maza MP; Chichester C; Hirsch S; Petermann M; Iturriaga H; Bunout D
Rev Med Chil; 1997 Jan; 125(1):15-21. PubMed ID: 9336064
[TBL] [Abstract][Full Text] [Related]
16. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
17. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
Jensen LT
Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
19. Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.
Liu YS; Xu GY; Cheng DQ; Li YM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):265-8. PubMed ID: 15908327
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
